Green Life Science: Q1 2026 Sales Surge 219%, Operating Profit Turns Positive

Sales 15.5 billion won, up 219% YoY (expansion in pharmaceutical intermediates and electronic materials)
Operating profit 0.58 billion won (vs 0.20 billion), net income 1.76 billion won (vs -1.15 billion), turning to black
EPS 88 won (vs -60 won)
Debt ratio 39.9%, current ratio 217.1%, very sound financial structure
Treasury shares 162,530 (0.81%), no dividends
Related party transactions: sales to Green Chemical 10.7 billion won, purchases 6.2 billion won
Auditor changed from Samjong to Seowoo
R&D expense 0.15 billion won (1.17% of sales), recognized impairment loss on intangible assets 0.13 billion won